Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,430 | -97,090 | -73,201 | -39,691 | -14,864 |
| Depreciation Amortization | 119 | 551 | 434 | 149 | 74 |
| Accounts receivable | 236 | 4,181 | 3,036 | -94 | -191 |
| Accounts payable and accrued liabilities | 171 | 1,422 | -606 | 809 | -194 |
| Other Working Capital | 5,642 | -251 | 2,369 | -9,617 | -6,910 |
| Other Operating Activity | -264 | 12,949 | 11,697 | 9,948 | 2,516 |
| Operating Cash Flow | $-13,526 | $-78,238 | $-56,271 | $-38,496 | $-19,569 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 99,835 | 74,814 | 56,288 | 23,436 |
| PPE Investments | -9 | -12,117 | -11,970 | -11,900 | -4,209 |
| Purchase Sale Intangibles | N/A | -195 | -190 | -145 | -62 |
| Other Investing Activity | 0 | -195 | -190 | -145 | -62 |
| Investing Cash Flow | $-9 | $87,523 | $62,654 | $44,243 | $19,165 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,300 | 65,216 | 52,681 | 52,556 | 34,284 |
| Other Financing Activity | -119 | -118 | -118 | -118 | 135 |
| Financing Cash Flow | $3,181 | $65,098 | $52,563 | $52,438 | $34,419 |
| Beginning Cash Position | 190,335 | 115,952 | 115,952 | 115,952 | 115,952 |
| End Cash Position | 179,981 | 190,335 | 174,898 | 174,137 | 149,967 |
| Net Cash Flow | $-10,354 | $74,383 | $58,946 | $58,185 | $34,015 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,526 | -78,238 | -56,271 | -38,496 | -19,569 |
| Capital Expenditure | -9 | -12,117 | -11,970 | -11,900 | -4,209 |
| Free Cash Flow | -13,535 | -90,355 | -68,241 | -50,396 | -23,778 |